198 related articles for article (PubMed ID: 29424903)
1. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
Fang C; Wang FB; Li Y; Zeng XT
Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer.
Ma J; Zhou Z
Breast Cancer; 2020 Mar; 27(2):291-298. PubMed ID: 31721061
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
[TBL] [Abstract][Full Text] [Related]
9. Expression of microRNA-497 and its prognostic significance in human breast cancer.
Wang S; Li H; Wang J; Wang D
Diagn Pathol; 2013 Oct; 8():172. PubMed ID: 24143964
[TBL] [Abstract][Full Text] [Related]
10. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
14. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
17. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
Song CG; Wu XY; Wang C; Fu FM; Shao ZM
Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
[TBL] [Abstract][Full Text] [Related]
19. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]